Indiana Trust & Investment Management’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Indiana Trust & Investment Management’s Portfolio NVIV Stock Details NVIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2	Closed	-$1	–	491
2023 Q4	$1	Hold	2	–	–	﹤0.01%	447
2023 Q3	$2	Buy	+2	New	+$2	﹤0.01%	438
2018 Q2	–	Sell	-1	Closed	-$10K	–	135
2018 Q1	$10K	Hold	1	–	–	﹤0.01%	133
2017 Q4	$15K	Hold	1	–	–	0.01%	133
2017 Q3	$28K	Hold	1	–	–	0.01%	126
2017 Q2	$52K	Hold	1	–	–	0.03%	125
2017 Q1	$54K	Hold	1	–	–	0.03%	124
2016 Q4	$56K	Hold	1	–	–	0.03%	119
2016 Q3	$90K	Hold	1	–	–	0.04%	126
2016 Q2	$77K	Hold	1	–	–	0.04%	125
2016 Q1	$92K	Buy	+1	New	+$107K	0.05%	117

Other funds holding NVIV

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vima LLC Troy, Michigan $103M AUM

Indiana Trust & Investment Management's NVIV Position: Q1 2024 in Review

Indiana Trust & Investment Management sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q1 2024, closing a stake of 2 shares — an estimated $1 sold.

Indiana Trust & Investment Management first reported a position in NVIV in Q1 2016 and held it in 11 quarters. The position peaked at $92K in Q1 2016. 4 funds tracked by Wall St. Rank hold NVIV as of Q1 2024.

Indiana Trust & Investment Management reported no remaining InVivo Therapeutics Holdings Corp position as of Q1 2024 after selling out during the quarter.
Indiana Trust & Investment Management sold 2 InVivo Therapeutics Holdings Corp shares in Q1 2024, an estimated $1.
Indiana Trust & Investment Management first reported a position in InVivo Therapeutics Holdings Corp in Q1 2016 and held it in 11 quarters.
Indiana Trust & Investment Management's InVivo Therapeutics Holdings Corp position peaked at $92K in Q1 2016.
4 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q1 2024.

Based on Indiana Trust & Investment Management's 13F filing for Q1 2024, filed 16 Apr 2024.